Author

Yi Liu

Mayo Clinic in FloridaORCID 0000-0002-3744-0590Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yi Liu8 papers · Jilin University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alfredo Quiñones‐HinojosaiD· 1 shared Ashley N. Haddock· 1 shared Athanassios Dovas· 1 shared Courtney A. MilleriD· 1 shared Debrabrata Mukhopadhyay· 1 shared E. Aubrey ThompsoniD· 1 shared Eugene F. DouglassiD· 1 shared Jane Lowe MeiseliD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alfredo Quiñones‐HinojosaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Spatial Logic Reconciles Gene-signature Methods in Triple Negative Breast Cancer

William C Bastian, Jane Lowe Meisel, Ji‐Hoon Lee, Nada Shaker, Lyra M. Griffiths, Meili Aiello, Zachary S. Buchwald, Yi Liu, E. Aubrey Thompson, Zaibo Li, Eugene F. Douglass, Xiaoxian Li

This study compares immune cell deconvolution and cancer subtype gene signatures in TNBC, finding that immune aggregates better predict outcomes than subtype signatures.

bioRxiv · Aug 18, 2026 · PreprintCancer Biology

Microtubule Acetylation Regulates the Malignant Phenotype of Glioblastoma and is a Promising Therapeutic Target

Natanael Zarco, Athanassios Dovas, Santanu Bhattacharya, Tanmay Kulkarni, Misha Amini, Yi Liu, Ashley N. Haddock, Naveen K H Nagaiah, Debrabrata Mukhopadhyay, Paola Suárez-Meade, Alfredo Quiñones‐Hinojosa, Courtney A. Miller, Theodore M. Kamenecka, Peter Canoll, Rajappa S. Kenchappa, Steven S. Rosenfeld

This study identifies ATAT1 as a therapeutic target in glioblastoma by showing its role in promoting tumor invasion, proliferation, and resistance, with potential for combination therapies.

bioRxiv · Jun 19, 2026 · PreprintCancer Biology